Objective: To identify copy number variant (CNV) causes of periventricular nodular heterotopia (PNH) in patients for whom FLNA sequencing is negative.
due to genetic heterogeneity. [7] [8] [9] [10] Alternatively, lesions in Filamin A undetectable by traditional sequencing may also cause disease. One category of such lesions is copy number variants (CNVs), which are an increasingly recognized cause of disease 11, 12 and trait variation. [13] [14] [15] FLNA resides in a rearrangement-prone region of the X chromosome at Xq28. 16, 17 We hypothesized that CNVs in this region might represent a previously unrecognized cause of PNH.
Here, we describe 3 patients with pathogenic FLNA CNVs as a cause of otherwise unexplained PNH. Custom tiling oligo comparative genomic hybridization (CGH) revealed distinct CNV boundaries consistent with rare, nonrecurrent events, likely stimulated by nearby genomic low copy repeats (LCRs). These results demonstrate that genomic rearrangements are an important cause of FLNA mutation, and establish the clinical importance of screening for such rearrangements in PNH.
METHODS Diagnosis. Clinically suspected PNH in patients was confirmed by brain MRI. Affymetrix 6.0 microarray analysis. DNA samples were analyzed on an Affymetrix genome-wide SNP Array 6.0. Data were processed using Birdsuite 18 to identify candidate copy number changes. Birdsuite calls were loaded into a MySQL database and filtered by score (lod Ͼ6) to generate a list of candidate CNVs. Separately, SNP calls were analyzed using PennCNV 19 with the software's recommended default settings.
Multiple ligation dependent probe amplification analysis. Multiple ligation dependent probe amplification (MLPA)
analysis was performed in individuals from 3 families using the Lissencephaly probe kit (SALSA P061-B2, MRC Holland, Amsterdam, the Netherlands), including 7 paired probes specific for the FLNA gene (exons 4, 11, 22, 25, 29, 39 , and 46). The resulting products were separated and sized on an ABI 3130XL sequencer (Applied Biosystems). Analysis was performed according to the manufacturer protocol.
Quantitative PCR validation. Taqman copy number assays from Applied Biosystems were used to validate CNVs ( figure 1B, table 1 ). The proband (II-2) experienced seizures resistant to multiple antiepileptics beginning in childhood. Her cognitive development and capabilities were within normal limits. MRI demonstrated classic, bilateral PNH (figure 2). The proband's mother, I-2, and the proband's daughter, III-1, were both asymptomatic and their diagnoses were ascertained after PNH was diagnosed in the proband, II-2.
Three generations of women in family 3 are affected by bilateral PNH (figure 1B, table 1), with some additional pathogenic features. The proband III-1 was born at 39 weeks to a 40-year-old mother, II-2. The pregnancy was significant for slowed intra-uterine growth from 28 to 29 weeks. At 2 months of age, she became irritable, with decreased feeding, poor sleep, stridor, and weak cry. She was admitted to the hospital where investigations revealed right ventricular hypertrophy, a patent foramen ovale, and pulmonary emphysema affecting multiple lobes. She was seen by the Genetics team because of possible dysmorphic features (blue sclerae, joint hypermobility, and loose skin); routine chromosome analysis and array CGH studies were normal. Her pulmonary function deteriorated progressively, and she died of respiratory insufficiency at 7 months. Autopsy showed bilateral, symmetric PNH, pulmonary panacinar emphysema, and tricuspid and mitral valve dysplasia. Her mother and grandmother were subsequently also diagnosed with PNH. Her mother also had cardiac valvular abnormalities and apical bullae of the lungs; her grandmother had lobar emphysema. No seizures were evident in any of the 3 affected individuals. . When normalized to a female control, it is apparent that the affected mother and daughter have one copy of the allele at that location, whereas the female control has 2 copies. The father, I-1, has one copy, which is expected for an unaffected male. The 95% confidence intervals were calculated using CopyCaller software by Applied Biosystems.
ing data were used to screen for CNVs using 2 algorithms, Birdsuite 18 and PennCNV. 19 Applying Birdsuite, we found 3 patients with evidence suggestive of copy number loss overlapping FLNA. Only one of these events was predicted with PennCNV, and qPCR confirmed only the single true positive. In this female individual (figure 1B, family 1, individual II-1), Birdsuite predicted a single copy deletion spanning 19.8 kb (hg18, chrX:153,228,832-153,248,612), disrupting the 3Ј end of FLNA. qPCR in the proband using multiple probes spanning the FLNA locus, as well as MLPA, confirmed a copy number of 1 over this interval (data not shown); this copy number change was also found in 2 other affected family members (figure 1C, family 1, sister II-2, and mother I-2), both of whom had MRIconfirmed PNH (figure 2).
To understand the rearrangement that led to this copy number change, we generated a custom microarray to fine-tile the FLNA locus with overlapping 40 -60 bp probes at a spacing of 15-30 bp, and performed CGH. CGH of individual I-2 from family 1 confirmed the presence of a FLNA 3Ј deletion, which was significantly larger than originally predicted by the Affymetrix 6.0 data. Decreased signal intensities were observed over the entire TKTL1 gene and nearly all of FLNA, consistent with loss of a single copy ( figure 3, second panel) . This lesion spares only FLNA exon 1 (noncoding) and FLNA exon 2 (the first coding exon), and is therefore predicted to abrogate FLNA function. The remainder of the locus demonstrated partially depressed signal intensities over the ϳ120 kb region centromeric to TKTL1, as well as over both inverted 11.3 kb LCRs flanking FLNA (figure 3, second panel). The former region contains 3 39-kb direct LCRs that include the opsin genes responsible for human color vision. 20 Each repeating subunit contains one copy of the opsin gene OPN1 and one copy of TEX28 ( figure 3, first panel) . Since the CGH probes in the OPN1-TEX28 locus cannot distinguish one direct repeat from another, a deletion of one of the 3 LCRs on one chromosome would be predicted to cause a one-sixth reduction in observed copy number relative to a diploid control [expected log2ratio of log2(5/6) ϭ Ϫ0.26]. We therefore interpret the slight but uniform decrease in log2ratio across the OPN1-TEX28 region to indicate deletion of one of the 3 LCRs on one chromosome.
Molecular investigations in families 2 and 3. Screening additional cohorts of PNH families using MLPA The y-axis represents the log2 ratio of the signal intensity from the patient compared to a reference female control. Tall striped rectangles ϭ inferred deletions; tall filled rectangle ϭ inferred duplications; short striped and solid rectangles ϭ regions of slightly decreased and increased signal intensity, respectively, across entire OPN1-TEX28 locus; green, red, blue shading ϭ TKTL1, FLNA, EMD gene loci, respectively; gray hashes and short arrows ϭ boundaries and direction of the inverted repeats flanking FLNA and EMD; gray vertical lines and long arrows ϭ boundaries and direction of the OPN1-TEX28 tandem repeats. CNV ϭ copy number variant.
revealed 21 There is also a slight but uniform increase in signal intensity in the OPN1-TEX28 tandem repeat region, consistent with a duplication of one repeat on one chromosome [expected log2ratio, log2(7/6) ϭ 0.22].
Family 3 is another 3-generation family exhibiting X-linked PNH (figures 1B and 2). MLPA screening of individual III-1 and her mother II-2 revealed a FLNA copy number loss (data not shown), and finetiling array CGH in II-2 demonstrated a 39-kb deletion with breakpoints mapping to the 11.3-kb inverted LCRs ( figure 3, fourth panel) . The identical deletion was detected by array CGH in individual III-1 (data not shown). This deletion removes one copy of the entire FLNA gene, providing an explanation for PNH in this pedigree. The deletion also removes one copy of the neighboring EMD gene. Mutations in EMD cause X-linked recessive EmeryDreifuss muscular dystrophy, a degenerative myopathy without involvement of the CNS. 22 Female carriers of EMD mutations are at risk for cardiac abnormalities, including cardiomyopathy and conduction defects. 23, 24 Junctional breakpoint analysis. A series of PCR assays were designed to interrogate the rearrangement breakpoint junctions. We successfully identified breakpoint PCR products in 2 of the 3 families. In family 1, PCR was attempted under the assumption of a simple, contiguous 113-kb deletion extending from TKTL1 to FLNA (see Discussion). A junctional amplification product was obtained of the approximate size predicted (data not shown), but sequence analysis revealed evidence of a more complex mechanism. Instead of a contiguous 113-kb deletion, the junctional product contained sequence from TEX28 intron 1, followed by an apparent 1,700-bp deletion, followed by 10 base pairs of TEX28 promoter, followed by a 33,403-bp deletion, followed by 43 base pairs of TEX28 intron 1, followed by a 77,942-bp deletion, followed by sequence from FLNA intron 2 (figure 4A). Closer inspection revealed 2 to 3 base pairs of microhomology between adjacent fragments (figure 4A).
In family 2, array CGH data suggested a head-totail partial duplication of FLNA (see Discussion). We designed PCR primers extending in the centromeric direction from exon 20 and from exon 41 and successfully obtained an amplification product, analysis of which revealed a junction between FLNA intron 41 and exon 20 ( figure 4B ). Three base pairs of microhomology were shared between the 2 fragments. DISCUSSION Point mutations in FLNA are found in most but not all patients with X-linked familial PNH, and only 26% of sporadic cases, 5, 6 suggesting the existence of other causative genetic lesions. Here, we applied a variety of methods to identify CNVs overlapping FLNA in patients with developmental brain disorders. Three families harboring pathogenic FLNA deletions are described: family 1, carrying a deletion of the majority of the 3Ј end of FLNA; family 2, with a deletion of the 3Ј end of FLNA and partial duplication of the 5Ј end and EMD; and family 3, with a deletion of the entire FLNA gene and EMD. Deletions of EMD have been previously described, 16, 17 but to our knowledge, this is the first report of deletion involving both EMD and FLNA.
The FLNA-EMD locus has been reported to be prone to genomic rearrangements, likely stimulated by multiple LCRs in the region. 16 Two 11.3-kb inverted repeats flank FLNA and EMD. Inverted repeats promote genomic instability 25 by a variety of mechanisms, 26, 27 one of which is nonallelic homologous recombination (NAHR). NAHR between the inverted repeats results in benign inversion of FLNA-EMD in up to 18% of patients of European descent. 16 Mispairing between the highly homologous 11.3-kb inverted repeats, followed by nonhomologous end joining (NHEJ) between an intervening Alu element and FLNA intron 28, was shown to result in deletion of EMD (and partial duplication of FLNA) in a patient with Emery-Dreifuss muscular dystrophy. 16 Inspection of the copy number pattern observed in family 2 (figure 3) suggests a similar mechanism of rearrangement (figure 4B): NAHR between 2 misaligned inverted repeats, followed by NHEJ between exon 20 of FLNA and intron 41 of FLNA on the opposite chromatid, resulting in deletion of the 3Ј end of FLNA and head-to-tail duplication of the 5Ј end of FLNA and EMD. Alternatively, a second model is possible in which this rearrangement first occurred in a maternal ancestor heterozygous for one copy of the benign FLNA-EMD inversion (figure 4B). NAHR between properly aligned LCRs, followed by NHEJ between FLNA exon 20 and intron 41, would result in the same final product.
The boundaries of the FLNA deletion observed in family 1 suggest a distinct, more complicated mecha- Copy number changes at the FLNA locus in 3 families with periventricular nodular heterotopia implicate distinct molecular mechanisms (A) Breakpoint sequencing supports a mechanism for family 1 rearrangement involving replication fork stalling and template switching/microhomology-mediated break-induced replication with template switches occurring between the second OPN1-TEX28 tandem repeat, the junction between the first and second OPN1-TEX28 tandem repeats, the third OPN1-TEX28 repeat, and FLNA intron 2. The result is loss of 1 OPN1-TEX28 tandem repeat and a deletion of all but the 5Ј end of FLNA. (B) Breakpoint sequencing in family 2 supports 2 alternative models. In model 1, nonallelic homologous recombination between mispaired inverted repeats is followed by nonhomologous end joining (NHEJ) between 2 inverted copies of FLNA on opposite chromatids, leading to deletion of the 3Ј end of FLNA and duplication of the 5Ј end of FLNA and EMD. Model 2 presupposes a heterozygous background for the benign FLNA-EMD inversion, in which case a single NHEJ event between FLNA intron 41 on one chromatid and FLNA exon 20 on the second chromatid is sufficient to generate the observed rearrangement. (C) A speculative, replicationbased model for FLNA rearrangement in family 3, in which the inverted repeats flanking FLNA and EMD form a single-strand secondary structure that results in contiguous deletion of both genes and the inner half of both repeats.
nism. While array CGH results (figure 3) initially suggested a single 113-kb deletion, breakpoint sequencing revealed that the expected contiguous deletion was actually interrupted by 2 sequences, 10 and 43 base pairs long, corresponding to sequences upstream of the TEX28 5Ј UTR and sequences from TEX28 intron 1, respectively, with 2-3 base pairs of microhomology at each sequence junction ( figure  4A ). This pattern, in which the resulting product appears as if the polymerase "skipped" several times across the template with evidence of microhomology at each junction, suggests that the family 1 rearrangement arose via a replication Fork Stalling and Template Switching (FoSTeS)/microhomology-mediated break-induced replication (MMBIR). 28 FoSTeS/ MMBIR has been observed to underlie other CNVassociated disorders such as Pelizaeus-Merzbacher disease (PMD), 29 Potocki-Lupski microduplication syndrome (PTLS)/Smith-Magenis microdeletion syndrome, and Charcot-Marie-Tooth disease type 1A (CMT1A). 30 The resulting product in family 1 is an allele deleting one OPN1-TEX28 unit, all of TKTL1 and the centromeric 11.3-kb inverted repeat, and the 3Ј end of FLNA (figure 4A). We believe the PNH phenotype in this family is explained entirely by the FLNA truncation; to our knowledge, no clinical diseases have been ascribed to TKTL1 haploinsufficiency, although there are hypothesized links to susceptibility to Wernicke-Korsakoff syndrome. [31] [32] [33] [34] In family 3, array CGH predicts a clean excision of FLNA and EMD, as well as the inner half of each flanking repeat. This is despite the fact that direct homologous recombination between 2 inverted repeats is expected to cause inversion, not deletion. Examination of the Alu-rich inverted repeats for direct repeats that could lead to deletion revealed no such sequence (data not shown). We speculate that a mechanism for the family 3 rearrangement might be one akin to replication slippage, 28 in which the inverted DNA repeats-exposed during replication as single-stranded DNA-form a secondary structure that leads to deletion of the intervening DNA ( figure  4C ). This explanation is not wholly satisfactory, however, as the size of this deletion (39 kb) is considerably larger than those typically observed in replication slippage. Since we were unable to amplify the breakpoint sequence, we cannot rule out the possibility of FoSTeS/MMBIR in this family as well.
The reported spectrum of clinically relevant FLNA variations includes not only loss-of-function mutations (resulting in PNH) but also gain-offunction mutations (resulting in otopalatodigital spectrum disorders) and partial loss-of-function mutations (associated with milder PNH and male survival). 35 The clinical presentations of the patients in this study are generally indistinguishable from those of other loss-of-function alleles. This is consistent with these lesions acting as molecular nulls. Affected individuals in family 3 exhibited additional pulmonary abnormalities, a finding that has been recently reported in 2 cases, in the setting of a missense mutation (p.G74R) and a truncating mutation (p.K331X). 36, 37 Our finding that deletion can phenocopy these changes indicates that the pulmonary phenotype is the result of FLNA loss-offunction, rather than a novel gain-of-function effect specific to the 2 other alleles. Although the true incidence of pulmonary disease in individuals with FLNA mutation remains to be established, it is unclear why pulmonary abnormalities are more severe in some individuals. In this respect, while affected individuals in family 3 are unique in that they harbor a concomitant EMD deletion, this is probably insufficient to account for their pulmonary presentation: EMD mutations are not known to affect the lung, and the previously reported pulmonary cases 36, 37 are not known to have additional mutations in EMD.
Here we have described 3 cases of FLNA genomic rearrangements leading to PNH, each with a unique pattern of copy number loss or gain that implies distinct, nonrecurrent mutational mechanisms. These results add to the rich variety of human variation documented at the Xq28 locus-opsin gene deletion causing color blindness, benign FLNA-EMD inversion, EMD deletion causing muscular dystrophy, and now FLNA disruption causing PNH-and underscore the importance of molecular screening for such rearrangements. 
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